Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
Conditions
Chronic Kidney Diseases · Calciphylaxis · Calcific Uremic Arteriolopathy · Treatment · Safety · Efficacy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China
Study leads
Ningning Wang, Professor
Principal Investigator
The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital
Jiayin Liu, Professor
Study Director
The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital
Lianju Qin
Principal Investigator
The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital